American College of Clinical Pharmacy
      Search      Cart
         

2018 ACCP/ASHP BCOP Clinical Sessions



An ACCP Publication


ACCP   ASHP

Jointly sponsored by ACCP and the American Society of Health-System Pharmacists

 

Session Overview

This educational series explores cutting-edge, contemporary therapeutic topics, and demonstrates scientifically sound clinical reasoning and decision-making. It employs learning activities designed to advance the participants’ skills and abilities to critically evaluate the scientific evidence and to effectively incorporate into daily practice significant findings that lead to effective and safe patient care.

Program Content

The 2018 BCOP Clinical Sessions are offered in two parts. The first part is focused Cardiology-Oncology and the second part of the BCOP Clinical Sessions will examine Immunotherapy.

Faculty
Sandra Cuellar Puri, Pharm.D., BCOP
Clinical Assistant Professor, University of Illinois Medical Center; Clinical Oncology Pharmacist, University Illinois at Chicago, Chicago, Illinois
Jo Ellen Rodgers, Pharm.D., FCCP, FAHA, FHFSA, BCPS-AQ Cardiology Jo Ellen Rodgers, Pharm.D., FCCP, FAHA, FHFSA, BCPS-AQ Cardiology
Clinical Professor, Division of Pharmacotherapy and Experimental Therapeutics, School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina
James E. Tisdale, Pharm.D., FCCP, FAPhA, FNAP, FAHA, BCPS James E. Tisdale, Pharm.D., FCCP, FAPhA, FNAP, FAHA, BCPS
Professor, Department of Pharmacy Practice, College of Pharmacy, Purdue University, and Adjunct Professor, School of Medicine, Indiana University, Indianapolis, Indiana
Jenna M. Carmichael, Pharm.D., BCOP Jenna M. Carmichael, Pharm.D., BCOP
Clinical Pharmacist, MTDM Oral Chemotherapy; RPD, PGY2 Oncology Residency Program; Geisinger Health, Wilkes-Barre, Pennsylvania
Tanya J. Uritsky, Pharm.D., BCPS, CPE Tanya J. Uritsky, Pharm.D., BCPS, CPE
Clinical Pharmacy Specialist Pain Management and Palliative Care Hospital of the University of Pennsylvania, Bryn Mawr, Pennsylvania

 

Target Audience and Program Goals

Clinical Pharmacists and BCOPs providing care to patients with cancer.

At the conclusion of the program, the participant should be able to:

Advances in Cardio-Oncology: Prevention and Management of Cardiovascular Complications Associated with Anticancer Therapies

  1. Identify risk factors for chemotherapy-associated heart failure (HF) and differentiate this risk among the various chemotherapies.
  2. Compare and contrast various diagnostic tools for identifying chemotherapy-associated HF.
  3. Identify various strategies to minimize the risk of chemotherapy-associated HF.
  4. Describe the role of pharmacotherapy in the primary and secondary prevention of chemotherapy-associated HF.
  5. Review anticancer therapies that cause vascular toxicities.
  6. Describe pathophysiology of anticancer therapies induced vascular toxicities.
  7. Describe monitoring and management of vascular toxicities cause by anticancer therapy.
  8. Describes the types of arrhythmias that may be caused by cancer chemotherapy drugs.
  9. Describe the pathophysiology and adverse outcomes associated with cancer chemotherapy-associated arrhythmias.
  10. Describe strategies for prevention and management of cancer chemotherapy-associated arrhythmias.

Do You Immuno? Supporting Patients with Advanced Malignancy Receiving Immunotherapy – From Symptom Management to Effective Communication and Beyond!

  1. List current indications for immunotherapy in oncology.
  2. Summarize potential adverse effects of immunotherapies.
  3. Review new ASCO and ESMO guidelines on supportive care management.
  4. Develop a supportive care plan for a patient experiencing adverse effects from immunotherapy, including agent selection and monitoring parameters.
  5. Describe the ethical considerations around utilization of immunotherapies in advanced illness.
  6. Given a patient case, describe the elements of a short, effective counseling session pertaining to initiation and monitoring for patients starting immunotherapy treatments.

 

Continuing Pharmacy Education Credit

ACPE The American College of Clinical Pharmacy is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.

Both BCOP Clinical Sessions are application-based activities.

BCOP Clinical Sessions—Advances in Cardio-Oncology: Prevention and Management of Cardiovascular Complications Associated with Anticancer Therapies
Activity Number: 0217-9999-18-158-H01-P
2.0 Hours of CPE Credit

BCOP Clinical Sessions—Do You Immuno? Supporting Patients with Advanced Malignancy Receiving Immunotherapy – From Symptom Management to Effective Communication and Beyond!
Activity Number: 0217-9999-18-165-H01-P
2.0 Hours of CPE Credit

To earn continuing pharmacy education (CPE) credit and to receive your continuing pharmacy education statement of credit for this activity, participants must successfully complete a Web-based posttest by October 1, 2019. Partial credit is not available for each activity.

BCOP Specialty Recertification Credit

To be eligible for 4.0 CPE hours of recertification credit, BCOPs must listen to all 4.0 contact hours of the recorded presentations and then successfully complete a Web-based posttest by March 31, 2019. Partial credit is available for this activity.

ACCP, as the official provider approved by BPS, will record and report recertification credit earned for this activity directly to BPS.

Technical Requirements

Requires an Internet browser and Adobe Reader.
 

Fees

ASHP members, please call (913) 492-3311 to receive the member discount.

Description Price Nonmember Cart
Specialty Recertification Program with 4.0 Continuing Education Credits
Includes audio/slide synchronized presentations, handouts, and online CPE test. The ACPE Universal Activity Number is listed under Continuing Pharmacy Education Credit above.
Test submission deadline for recertification is March 31, 2019.
$150.00 $210.00
Online Program with 4.0 Continuing Education Credits (CPE only)
Includes audio/slide synchronized presentations, handouts, and online CPE test. The ACPE Universal Activity Number is listed under Continuing Pharmacy Education Credit above.
This product does not include specialty recertification credit. Test submission deadline for CPE credit is October 1, 2019.
$100.00 $160.00

 

Please note that the posttest will not be available until December 15, 2018.

Financial Support

 

No financial support from external supporters was obtained for this course.